Methodist Journal

FEATURED GUEST EDITOR

ISSUE INTRO

The Burgeoning Field of Cardio-Oncology

See More
RECOGNITIONS

Barry H. Trachtenberg Leads Issue on Cardio-Oncology

See More

REVIEW ARTICLES See More

Heart Failure in Relation to Anthracyclines and Other Chemotherapies

Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies

The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics

Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity

Cardiovascular Toxicities of Radiation Therapy

Electrophysiologic Complications in Cancer Patients

Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?

Future Directions in Cardio-Oncology

CASE REPORTS See More

A Rare Case of Pancreatitis-Induced Thrombosis of the Aorta and Superior Mesenteric Artery

Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis

Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve

Uneventful Follow-Up 2 Years after Endovascular Treatment of a High Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure

MUSEUM OF HMH MULTIMODALITY IMAGING CENTER See More

Do Not Pass Flow: Microvascular Obstruction on Cardiac Magnetic Resonance After Reinfarction Following Primary Percutaneous Coronary Intervention

CLINICAL PERSPECTIVES See More

EXCERPTA

Cardio-Oncology, Then and Now: An Interview with Barry Trachtenberg

POINTS TO REMEMBER

Onconephrology: An Evolving Field

POINTS TO REMEMBER

Herbal Nephropathy

EXCERPTA

Rolling the Dice on Red Yeast Rice

EDITORIALS

Letter to the Editor in Response to “Cardiac Autonomic Neuropathy in Diabetes Mellitus”

Vol 15, Issue 4 (2019)

Article Full Text

RECOGNITIONS

Barry H. Trachtenberg Leads Issue on Cardio-Oncology

Jump to:
Article Citation:

Barry H. Trachtenberg Leads Issue on Cardio-Oncology. Methodist DeBakey Cardiovasc J. 2019;15(4):240.



Barry H. Trachtenberg, MD

The editors of the Methodist DeBakey Cardiovascular Journal are grateful to Barry H. Trachtenberg, MD, for his expert guidance in putting together this special issue on cardio-oncology.

Dr. Trachtenberg is a cardiologist specializing in cardio-oncology, heart failure, and cardiac transplantation at Houston Methodist Hospital and assistant professor of cardiology at Weill Cornell Medical College. He is the founder and director of the cardio-oncology program at Houston Methodist, where he works closely with and is a member of the Houston Methodist Cancer Center. Dr. Trachtenberg leads a team of cardiovascular experts who use cutting-edge methods to prevent and manage cardiovascular complications of cancer therapies, including chemo/immunotherapies and radiation. He also directs the cardiac amyloidosis program and oversees the multidisciplinary amyloid working group.

In addition, he is associate director of the mechanical circulatory support program at the Methodist DeBakey Cardiology Associates. As program director for the Advanced Heart Failure Fellowship at Houston Methodist Hospital, Dr. Trachtenberg enjoys training the next generation of cardiologists to manage complex heart failure cases. Dr. Trachtenberg is board certified in internal medicine, cardiovascular disease, echocardiography, and advanced heart failure and transplantation.

After earning his Bachelor of Science degree from the University of Pennsylvania, Dr. Trachtenberg attended medical school at the University of Texas-San Antonio. Next, he returned to his hometown of Houston for an internal medicine residency at Baylor College of Medicine. He then completed a fellowship in cardiology and advanced heart failure at the University of Miami Miller School of Medicine in Florida.

Outside of his clinical duties, Dr. Trachtenberg has published numerous papers on topics related to advanced heart failure, inflammatory cardiomyopathies, ventricular assist devices, and cardio-oncology and contributed to dozens of clinical trials. He is also a member of the American Heart Association, the International Society for Heart and Lung Transplantation, the Heart Failure Society of America, and the International CardiOncology Society of North America. He is the heart failure chair for the Texas chapter of the American College of Cardiology.

Add Comments

Please login to dialogue with author.

Comments